ThirdAge

<img alt="" height="1" width="1" />
Parkinson&#39;s Drug Doesn&#39;t Slow Disease Progress, FDA Staff Says
MedPage Today
WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson&#39;s disease, does not appear effective at slowing progression of the neurodegenerative disease, ...
FDA questions Teva drug&#39;s impact on Parkinson&#39;sBusinessWeek
FDA reviewers unconvinced on Teva Parkinson&#39;s drugReuters
FDA questions Teva drug&#39;s impact on Parkinson&#39;sForbes
Fox Business -ThirdAge -FierceBiotech
all 25 news articles &raquo;


More...